Exact Sciences Corporation (FRA:EXK)

Exact Sciences Statistics

Total Valuation

Exact Sciences has a market cap or net worth of EUR 16.49 billion. The enterprise value is 17.81 billion.

Market Cap	16.49B
Enterprise Value	17.81B

Important Dates

The next estimated earnings date is Tuesday, February 17, 2026.

Earnings Date	Feb 17, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	189.47M
Shares Outstanding	n/a
Shares Change (YoY)	+2.42%
Shares Change (QoQ)	+0.19%
Owned by Insiders (%)	0.91%
Owned by Institutions (%)	95.06%
Float	187.64M

Valuation Ratios

PE Ratio	n/a
Forward PE	119.58
PS Ratio	6.28
PB Ratio	7.74
P/TBV Ratio	n/a
P/FCF Ratio	78.32
P/OCF Ratio	50.03
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 140.91, with an EV/FCF ratio of 84.58.

EV / Earnings	-21.18
EV / Sales	6.72
EV / EBITDA	140.91
EV / EBIT	n/a
EV / FCF	84.58

Financial Position

The company has a current ratio of 2.72, with a Debt / Equity ratio of 1.01.

Current Ratio	2.72
Quick Ratio	2.30
Debt / Equity	1.01
Debt / EBITDA	17.25
Debt / FCF	10.26
Interest Coverage	-3.82

Financial Efficiency

Return on equity (ROE) is -34.54% and return on invested capital (ROIC) is -1.25%.

Return on Equity (ROE)	-34.54%
Return on Assets (ROA)	-1.09%
Return on Invested Capital (ROIC)	-1.25%
Return on Capital Employed (ROCE)	-2.08%
Revenue Per Employee	377,959
Profits Per Employee	-120,987
Employee Count	7,000
Asset Turnover	0.49
Inventory Turnover	6.25

Taxes

Income Tax	-6.98M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +55.23% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+55.23%
50-Day Moving Average	57.74
200-Day Moving Average	47.06
Relative Strength Index (RSI)	86.62
Average Volume (20 Days)	79

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.56

Income Statement

In the last 12 months, Exact Sciences had revenue of EUR 2.63 billion and -840.86 million in losses. Loss per share was -4.49.

Revenue	2.63B
Gross Profit	1.82B
Operating Income	-94.09M
Pretax Income	-847.84M
Net Income	-840.86M
EBITDA	92.03M
EBIT	-94.09M
Loss Per Share	-4.49

Balance Sheet

The company has 854.94 million in cash and 2.16 billion in debt, giving a net cash position of -1.31 billion.

Cash & Cash Equivalents	854.94M
Total Debt	2.16B
Net Cash	-1.31B
Net Cash Per Share	n/a
Equity (Book Value)	2.13B
Book Value Per Share	11.25
Working Capital	857.81M

Cash Flow

In the last 12 months, operating cash flow was 329.68 million and capital expenditures -119.09 million, giving a free cash flow of 210.59 million.

Operating Cash Flow	329.68M
Capital Expenditures	-119.09M
Free Cash Flow	210.59M
FCF Per Share	n/a

Margins

Gross margin is 69.42%, with operating and profit margins of -3.58% and -32.01%.

Gross Margin	69.42%
Operating Margin	-3.58%
Pretax Margin	-32.28%
Profit Margin	-32.01%
EBITDA Margin	3.50%
EBIT Margin	-3.58%
FCF Margin	8.02%

Dividends & Yields

Exact Sciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.42%
Shareholder Yield	-2.42%
Earnings Yield	-5.10%
FCF Yield	1.28%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Exact Sciences has an Altman Z-Score of 1.33 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.33
Piotroski F-Score	5